Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionCNB Bank
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
CNB Bank closes position in EW / Edwards Lifesciences Corporation

On May 6, 2026 - CNB Bank filed a 13F-HR form disclosing ownership of 0 shares of Edwards Lifesciences Corporation (US:EW) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 89 shares of Edwards Lifesciences Corporation. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 0 -100.00 0
2026-02-11 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 89 0 0.00 8 16.67 0.0031
2025-10-30 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 89 0 0.00 7 0.00 0.0029
2025-07-31 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 89 0 0.00 7 0.00 0.0033
2025-04-24 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 89 0 0.00 6 0.00 0.0033
2025-01-15 2024-12-31 13F Edwards Lifesciences COM 28176E108 89 -898 -90.98 7 -90.77 0.0031
2024-10-18 2024-09-30 13F Edwards Lifesciences COM 28176E108 987 -1,071 -52.04 65 -65.79 0.0301
2024-08-08 2024-06-30 13F Edwards Lifesciences COM 28176E108 2,058 -257 -11.10 190 -14.03 0.0914
2024-05-02 2024-03-31 13F Edwards Lifesciences COM 28176E108 2,315 -152 -6.16 221 17.55 0.1079
2024-01-31 2023-12-31 13F Edwards Lifesciences COM 28176E108 2,467 -488 -16.51 188 -7.84 0.1010
2023-11-02 2023-09-30 13F Edwards Lifesciences COM 28176E108 2,955 -2,209 -42.78 205 -58.11 0.1205
2023-08-08 2023-06-30 13F Edwards Lifesciences COM 28176E108 5,164 -99 -1.88 487 11.95 0.2865
2023-05-10 2023-03-31 13F Edwards Lifesciences COM 28176E108 5,263 380 7.78 435 19.51 0.2650
2023-02-13 2022-12-31 13F Edwards Lifesciences COM 28176E108 4,883 422 9.46 364 -1.09 0.2278
2022-11-14 2022-09-30 13F Edwards Lifesciences COM 28176E108 4,461 334 8.09 368 -6.12 0.2490
2022-08-19 2022-06-30 13F/A-1 Edwards Lifesciences COM 28176E108 4,127 -60 -1.43 392 -20.65 0.2536
2022-08-10 2022-06-30 13F Edwards Lifesciences COM 28176E108 4,127 -60 392 0.1616
2022-04-13 2022-03-31 13F Edwards Lifesciences COM 28176E108 4,187 31 0.75 494 -8.18 0.2738
2022-01-31 2021-12-31 13F Edwards Lifesciences COM 28176E108 4,156 247 6.32 538 21.72 0.2948
2021-11-02 2021-09-30 13F Edwards Lifesciences COM 28176E108 3,909 268 7.36 442 17.55 0.2655
2021-07-29 2021-06-30 13F Edwards Lifesciences COM 28176E108 3,641 160 4.60 376 29.21 0.2351
2021-05-03 2021-03-31 13F Edwards Lifesciences COM 28176E108 3,481 543 18.48 291 8.58 0.2013
2021-01-27 2020-12-31 13F Edwards Lifesciences COM 28176E108 2,938 407 16.08 268 32.67 0.2024
2020-10-26 2020-09-30 13F Edwards Lifesciences COM 28176E108 2,531 -261 -9.35 202 4.66 0.1700
2020-07-14 2020-06-30 13F Edwards Lifesciences COM 28176E108 2,792 1,911 216.91 193 16.27 0.1699
2020-05-13 2020-03-31 13F Edwards Lifesciences COM 28176E108 881 86 10.82 166 -10.27 0.1788
2020-01-27 2019-12-31 13F Edwards Lifesciences COM 28176E108 795 16 2.05 185 8.19 0.1566
2019-11-04 2019-09-30 13F Edwards Lifesciences COM 28176E108 779 590 312.17 171 388.57 0.1583
2019-08-14 2019-06-30 13F Edwards Lifesciences COM 28176E108 189 189 35 0.0299
2018-05-11 2018-03-31 13F Edwards Lifesciences COM 28176E108 0 -94 -100.00 0 -100.00
2018-02-20 2017-12-31 13F Edwards Lifesciences COM 28176E108 94 94 11 0.0066
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.